Thermo Fisher Scientific TMO Balance Sheet

Income Statement

Quarter End	Jul 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	90.58B	90.54B	97.15B	94.66B	94.11B	97.06B	98.73B	97.1B
Total Current Assets	18.1B	19.3B	25.23B	20.21B	20B	23.09B	24.59B	23.64B
Cash and Equivalents	1.89B	2.92B	8.52B	3.48B	3.13B	6.15B	8.08B	5.5B
Total Non-Current Assets	72.48B	71.24B	81.21B	74.45B	74.11B	73.97B	83.59B	73.46B
Total Liabilities	48.11B	46.81B	53.01B	52.23B	50.19B	51.59B	51.88B	51.47B
Total Current Liabilities	11B	11.12B	17.01B	15.88B	14.11B	14.16B	14.01B	13.94B
Total Non-Current Liabilities	66.36B	63.84B	64.91B	65.48B	65.27B	67.92B	69.18B	68.69B
Common Equity	440M	440M	441M	441M	441M	442M	442M	443M
Retained Earnings	39.07B	40.45B	41.91B	43.06B	44.29B	45.87B	47.36B	48.54B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	45.91B	56.67B	56.23B	58.38B	69.05B	95.12B	97.15B	98.73B
Total Current Assets	7.02B	9.42B	10.63B	11.89B	21.96B	20.11B	25.23B	24.59B
Cash and Equivalents	786.2M	1.34B	2.1B	2.4B	10.33B	4.48B	8.52B	8.08B
Total Non-Current Assets	21.54B	25.41B	27.59B	29.68B	34.51B	40.86B	44.03B	46.72B
Total Liabilities	24.37B	31.26B	28.65B	28.71B	34.55B	54.15B	53.01B	51.88B
Total Current Liabilities	4.87B	7.05B	6.15B	6.2B	10.3B	13.44B	17.01B	14.01B
Total Non-Current Liabilities	34.87B	43.08B	40.22B	39.59B	43.35B	73.04B	64.91B	69.18B
Total Equity	21.54B	25.41B	27.59B	29.68B	34.51B	40.86B	44.03B	46.72B
Common Equity	415.1M	428M	432M	434M	437M	439M	441M	442M
Retained Earnings	13.93B	15.91B	18.7B	22.09B	28.12B	35.43B	41.91B	47.36B